"<p class="""" data-start=""101"" data-end=""117""><strong data-start=""101"" data-end=""117"">Introduction</strong></p>
<p class="""" data-start=""119"" data-end=""314""><span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">In vitro diagnostics (IVD) quality control is a critical component in the healthcare industry, ensuring the accuracy and reliability of diagnostic tests performed outside the human body.</span> <span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">These tests are essential for disease detection, management, and prevention, making quality control indispensable.</span> <span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">Several key players dominate the IVD quality control market, contributing significantly to advancements in diagnostic accuracy and patient care.</span> <span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">This article provides a comprehensive analysis of prominent companies in the IVD quality control sector, focusing on Quidel Corporation, Bio-Techne, Alere Inc., Qiagen N.V., and Bio-Rad Laboratories Inc.</span></p>
<p class="""" data-start=""316"" data-end=""341""><strong data-start=""316"" data-end=""341"">1. Quidel Corporation</strong></p>
<p class="""" data-start=""343"" data-end=""442""><strong data-start=""343"" data-end=""360"">Headquarters:</strong> <span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">San Diego, California, USA</span></p>
<p class="""" data-start=""343"" data-end=""442""><strong>To Learn more about this Report, Request Free Sample PDF @&nbsp;<a href=""https://www.globalmarketstatistics.com/market-reports/in-vitro-diagnostics-ivd-quality-control-market-12490"">https://www.globalmarketstatistics.com/market-reports/in-vitro-diagnostics-ivd-quality-control-market-12490</a></strong></p>
<p class="""" data-start=""444"" data-end=""457""><strong data-start=""444"" data-end=""457"">Overview:</strong></p>
<p class="""" data-start=""459"" data-end=""618""><span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">Quidel Corporation is renowned for developing rapid diagnostic testing solutions, cellular-based virology assays, and molecular diagnostic systems.</span> <span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">The company's product portfolio includes diagnostic tests for infectious diseases, cardiovascular conditions, and autoimmune disorders.</span> <span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">Quidel's commitment to quality control is evident in its comprehensive range of products designed to ensure the accuracy and reliability of diagnostic results.</span></p>
<p class="""" data-start=""620"" data-end=""644""><strong data-start=""620"" data-end=""644"">Recent Developments:</strong></p>
<p class="""" data-start=""646"" data-end=""771""><span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">In July 2021, Quidel received the CE Mark for its innovative Savanna multiplex molecular analyzer and Savanna RVP4 Assay (Respiratory Viral Panel-4), enhancing its molecular diagnostics capabilities.</span></p>
<p class="""" data-start=""773"" data-end=""799""><strong data-start=""773"" data-end=""799"">Financial Performance:</strong></p>
<p class="""" data-start=""801"" data-end=""886""><span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">While specific revenue figures for Quidel's IVD quality control segment are not publicly disclosed, the company's overall financial performance has been robust, driven by increased demand for diagnostic testing, particularly during global health crises.</span></p>
<p class="""" data-start=""888"" data-end=""905""><strong data-start=""888"" data-end=""905"">2. Bio-Techne</strong></p>
<p class="""" data-start=""907"" data-end=""1010""><strong data-start=""907"" data-end=""924"">Headquarters:</strong> <span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">Minneapolis, Minnesota, USA</span></p>
<p class="""" data-start=""1012"" data-end=""1025""><strong data-start=""1012"" data-end=""1025"">Overview:</strong></p>
<p class="""" data-start=""1027"" data-end=""1152""><span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">Bio-Techne specializes in providing high-quality reagents, instruments, and services for the life sciences and clinical diagnostics markets.</span> <span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">The company's products are integral to research and diagnostic laboratories, ensuring the precision of various diagnostic tests.</span></p>
<p class="""" data-start=""1154"" data-end=""1178""><strong data-start=""1154"" data-end=""1178"">Recent Developments:</strong></p>
<p class="""" data-start=""1180"" data-end=""1305""><span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">In October 2024, Bio-Techne reported an adjusted profit of 42 cents per share for the first quarter, surpassing analysts' expectations, driven by growth in its diagnostics and spatial biology segment.</span></p>
<p class="""" data-start=""1307"" data-end=""1333""><strong data-start=""1307"" data-end=""1333"">Financial Performance:</strong></p>
<p class="""" data-start=""1335"" data-end=""1460""><span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">Bio-Techne's diagnostics and spatial biology revenue increased by 14% to $83.2 million in the reported quarter, reflecting the company's strong position in the IVD quality control market.</span></p>
<p class="""" data-start=""1335"" data-end=""1460""><span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]""><strong>To Learn more about this Report, Request Free Sample PDF @&nbsp;<a href=""https://www.globalmarketstatistics.com/market-reports/in-vitro-diagnostics-ivd-quality-control-market-12490"">https://www.globalmarketstatistics.com/market-reports/in-vitro-diagnostics-ivd-quality-control-market-12490</a></strong></span></p>
<p class="""" data-start=""1462"" data-end=""1479""><strong data-start=""1462"" data-end=""1479"">3. Alere Inc.</strong></p>
<p class="""" data-start=""1481"" data-end=""1584""><strong data-start=""1481"" data-end=""1498"">Headquarters:</strong> <span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">Waltham, Massachusetts, USA</span></p>
<p class="""" data-start=""1586"" data-end=""1599""><strong data-start=""1586"" data-end=""1599"">Overview:</strong></p>
<p class="""" data-start=""1601"" data-end=""1726""><span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">Alere Inc., now part of Abbott Laboratories, was a global leader in rapid diagnostic tests, offering point-of-care diagnostics for infectious diseases, cardiometabolic conditions, and toxicology.</span> <span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">The company's products were designed to deliver reliable results quickly, facilitating timely clinical decisions.</span></p>
<p class="""" data-start=""1728"" data-end=""1752""><strong data-start=""1728"" data-end=""1752"">Recent Developments:</strong></p>
<p class="""" data-start=""1754"" data-end=""1879""><span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">In October 2022, Thermo Fisher Scientific acquired The Binding Site Group, enhancing its specialty diagnostics segment, which includes products initially developed by companies like Alere.</span>&nbsp;</p>
<p class="""" data-start=""1881"" data-end=""1907""><strong data-start=""1881"" data-end=""1907"">Financial Performance:</strong></p>
<p class="""" data-start=""1909"" data-end=""1994""><span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">Post-acquisition, Abbott Laboratories has continued to report strong performance in its diagnostics segment, reflecting the enduring value of Alere's product portfolio.</span></p>
<p class="""" data-start=""1996"" data-end=""2014""><strong data-start=""1996"" data-end=""2014"">4. Qiagen N.V.</strong></p>
<p class="""" data-start=""2016"" data-end=""2119""><strong data-start=""2016"" data-end=""2033"">Headquarters:</strong> <span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">Venlo, Netherlands</span></p>
<p class="""" data-start=""2121"" data-end=""2134""><strong data-start=""2121"" data-end=""2134"">Overview:</strong></p>
<p class="""" data-start=""2136"" data-end=""2261""><span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">Qiagen N.V. is a leading provider of sample and assay technologies for molecular diagnostics, applied testing, and academic research.</span> <span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">The company's products are essential for extracting and processing DNA, RNA, and proteins, ensuring the accuracy of diagnostic tests.</span></p>
<p class="""" data-start=""2263"" data-end=""2287""><strong data-start=""2263"" data-end=""2287"">Recent Developments:</strong></p>
<p class="""" data-start=""2289"" data-end=""2414""><span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">In January 2023, Qiagen launched the EZ2 Connect MDx IVD platform for automated sampling in diagnostic laboratories, enhancing efficiency and reliability in sample processing.</span>&nbsp;</p>
<p class="""" data-start=""2416"" data-end=""2442""><strong data-start=""2416"" data-end=""2442"">Financial Performance:</strong></p>
<p class="""" data-start=""2444"" data-end=""2529""><span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">Qiagen has experienced steady growth, with its diagnostics segment contributing significantly to its overall revenue, driven by the increasing demand for molecular diagnostic solutions.</span></p>
<p class="""" data-start=""2444"" data-end=""2529""><strong>To Learn more about this Report, Request Free Sample PDF @&nbsp;<a href=""https://www.globalmarketstatistics.com/market-reports/in-vitro-diagnostics-ivd-quality-control-market-12490"">https://www.globalmarketstatistics.com/market-reports/in-vitro-diagnostics-ivd-quality-control-market-12490</a></strong></p>
<p class="""" data-start=""2531"" data-end=""2563""><strong data-start=""2531"" data-end=""2563"">5. Bio-Rad Laboratories Inc.</strong></p>
<p class="""" data-start=""2565"" data-end=""2668""><strong data-start=""2565"" data-end=""2582"">Headquarters:</strong> <span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">Hercules, California, USA</span></p>
<p class="""" data-start=""2670"" data-end=""2683""><strong data-start=""2670"" data-end=""2683"">Overview:</strong></p>
<p class="""" data-start=""2685"" data-end=""2810""><span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">Bio-Rad Laboratories Inc. develops and manufactures products for the life science research and clinical diagnostics markets.</span> <span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">The company's quality control products are widely used to ensure the accuracy of diagnostic tests across various applications.</span></p>
<p class="""" data-start=""2812"" data-end=""2836""><strong data-start=""2812"" data-end=""2836"">Recent Developments:</strong></p>
<p class="""" data-start=""2838"" data-end=""2963""><span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">In October 2024, Bio-Rad reported a 5.6% increase in sales in its clinical diagnostics segment, reaching $388.8 million, driven by strong demand for analytical tools from biotech clients.</span></p>
<p class="""" data-start=""2965"" data-end=""2991""><strong data-start=""2965"" data-end=""2991"">Financial Performance:</strong></p>
<p class="""" data-start=""2993"" data-end=""3118""><span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">Bio-Rad's total net sales for the quarter were $649.7 million, surpassing analysts' forecasts and reflecting the company's robust position in the IVD quality control market.</span></p>
<p class="""" data-start=""3120"" data-end=""3139""><strong data-start=""3120"" data-end=""3139"">Market Overview</strong></p>
<p class="""" data-start=""3141"" data-end=""3306""><span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">The global in vitro diagnostics (IVD) quality control market has been experiencing steady growth, driven by the increasing prevalence of chronic and infectious diseases, advancements in diagnostic technologies, and the growing adoption of third-party quality controls.</span> <span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">According to a report by MarketsandMarkets, the IVD quality control market is projected to grow from $1.3 billion in 2022 to $1.6 billion by 2027, at a compound annual growth rate (CAGR) of 5.4%.</span></p>
<p class="""" data-start=""3308"" data-end=""3331""><strong data-start=""3308"" data-end=""3331"">Key Market Drivers:</strong></p>
<ul data-start=""3333"" data-end=""3678"">
<li class="""" data-start=""3333"" data-end=""3455"">
<p class="""" data-start=""3335"" data-end=""3455""><strong data-start=""3335"" data-end=""3369"">Rising Prevalence of Diseases:</strong> <span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">The increasing incidence of diseases such as HIV, cancer, and cardiovascular conditions necessitates accurate diagnostic tests, thereby driving the demand for quality control products.</span></p>
</li>
<li class="""" data-start=""3457"" data-end=""3576"">
<p class="""" data-start=""3459"" data-end=""3576""><strong data-start=""3459"" data-end=""3490"">Technological Advancements:</strong> <span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]"">Innovations in diagnostic technologies, including molecular diagnostics and point-of-care testing, require robust quality control measures to ensure test accuracy and reliability.</span></p>
</li>
</ul>
<p><span class=""relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem]""><strong>To Learn more about this Report, Request Free Sample PDF @&nbsp;<a href=""https://www.globalmarketstatistics.com/market-reports/in-vitro-diagnostics-ivd-quality-control-market-12490"">https://www.globalmarketstatistics.com/market-reports/in-vitro-diagnostics-ivd-quality-control-market-12490</a></strong></span></p>"
